Latest News for: diabetes

Edit

Prof Tim Spector claims supplement could slash diabetes risk - but with a warning

The Mirror 21 Mar 2026
Studies are mixed on the impact this pill could have on diabetes ... .
Edit

Type 2 diabetes risk could be reduced by common pill

Daily Record 21 Mar 2026
Professor Tim Spector has shared that these supplements may help lower the risk of developing type 2 diabetes ... .
Edit

Dr Reddy’s launches semaglutide under brand name Obeda for diabetes management

Business Line 21 Mar 2026
The cost to the patient will be ₹4,200 per month ....
Edit

Women urged to prioritise health amid diabetes struggles

FBC News 21 Mar 2026
A woman living with Type 1 diabetes for two decades is urging ...
Edit

Type 1 Diabetes Linked To Higher Risk Of Dementia, Finds New Study

NDTV 21 Mar 2026
The researchers estimated that people with type 1 diabetes were nearly three times as likely to develop dementia as people without diabetes. People with type 2 diabetes were twice as likely to develop... .
Edit

Program aims to help cut diabetes risks

Leavenworth Times 21 Mar 2026
Login. Sign up for complimentary access ... Close. ....
Edit

Fatty Pancreas Detected In Nearly 50% Of Type 2 Diabetes Patients: Study

NDTV 21 Mar 2026
A recent study has found that nearly 54% of patients with type 2 diabetes (T2D) suffer from fatty pancreas disease (FPD) ... .
Edit

Here’s What Your Diabetes Risk Looks Like by Decade—and How To Lower Yours

The Capital Journal 21 Mar 2026
Learn how to protect yourself as diabetes rates rise ....
Edit

Indian pharma firms launch cheaper generic semaglutide for diabetes, obesity

Madhyamam 21 Mar 2026
Three major Indian drugmakers have introduced low-cost generic versions of Semaglutide injections following the expiry of its patent, expanding access for patients with Type 2 Diabetes and obesity.
Edit

Dr. Reddy’s Laboratories announces launch of India’s first DCGI-approved Semaglutide injection ‘Obeda®’ for Type 2 Diabetes (Dr Reddy's Laboratories Limited)

Public Technologies 21 Mar 2026
Reddy's Laboratories announces launch of India's first DCGI-approved Semaglutide injection 'Obeda®' for Type 2 Diabetes ... 2 diabetes in India ... 1 https.//idf.org/about-diabetes/diabetes-facts-figures/.
Edit

Lilly’s experimental diabetes shot yields record weight loss in study

Union Leader 20 Mar 2026
One of Eli Lilly & Co.’s most highly anticipated experimental medicines helped diabetic patients lose more weight than any drug currently on the market, underscoring its potential in the increasingly crowded race for next-generation therapies ....
×